Penn Medicine researchers use artificial intelligence to ‘redefine’ Alzheimer’s disease
With a $17.8 million grant from the National Institute on Aging at the National Institutes of Health, researchers in the Perelman School of Medicine will collaborate with 11 research centers to determine more precise diagnostic biomarkers and drug targets for the disease.
FULL STORY AT Penn Medicine News →